All In Biotech

Free tool

FAERS Monitor: Veklury

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 214787 or its brand name (Veklury, Remdesivir). Reports on generic versions are filed under their own applications.

Reports

13,295

Serious

11,170

84% of reports

Hospitalization

4,528

Death reported

3,305

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use2,245
  • alanine aminotransferase increased935
  • covid-19919
  • drug ineffective768
  • death762
  • bradycardia652
  • acute kidney injury630
  • aspartate aminotransferase increased629
  • respiratory failure552
  • covid-19 pneumonia505
  • liver function test increased422
  • condition aggravated396
  • pneumonia334
  • drug ineffective for unapproved indication327
  • blood creatinine increased323

Reports by year received

View as table
YearReports
20181
20194
20204,479
20212,859
20222,598
20231,647
20241,011
2025536
2026160

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,864 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
covid-19 pneumoniaSignal50570.664.733,141
liver function test increasedSignal42231.728.812,282
alanine aminotransferase increasedSignal93524.523.020,747
bradycardiaSignal65219.718.311,431
aspartate aminotransferase increasedSignal62918.917.510,576
respiratory failureSignal55212.111.15,563
drug ineffective for unapproved indicationSignal3279.58.52,463
covid-19Signal9198.37.85,934
blood creatinine increasedSignal3237.97.11,924
acute kidney injurySignal6306.56.12,958
off label useSignal2,2454.13.95,394
condition aggravatedSignal3962.11.9218
pneumonia3341.61.582
death7621.41.390
drug ineffective7680.90.95

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.